Should we be prepared to change the population composition of a species in order to wipe out a disease that is a terrible burden to mankind? During a well-attended working breakfast organised by the European Parliament’s Panel for the Future of Science and Technology (STOA) on 19 March 2019, experts and citizens delved into the case study of eradicating malaria by applying gene-drive technology. This genetic tool could enable us to suppress mosquito populations that transmit malaria by reducing the number of females. This would be done by introducing in some mosquitos a genetic mechanism that easily spreads – ‘drives’ – through the whole population over generations.
The purpose of the event was to gain insight into the science and ethics of gene-drive technology, and of genome-editing technologies in general. The meeting was chaired by Kay Swinburne, (ECR, UK) a STOA Panel member, who underlined the importance of invigorating public debate on such technologies in her opening statement. With more than 200 million cases of malaria each year worldwide, of which over 400 000 are fatal, no one doubts the importance of fighting this disease. This, as Kay Swinburne explained, makes the case less controversial than, for instance, human genome editing, and therefore it provides a good opportunity to focus on understanding the benefits of genetic technology. Such an understanding, combined with knowledge of the risks and concerns, and with awareness of different stakeholder perspectives, should help policy-makers anticipate the application of genome-editing technologies. With three expert presentations and a debate, this event provided input on all these fronts.
First, Jens Van Steerteghem, of KU Leuven, and a former STOA trainee, gave the audience a technical overview of gene-drive technology in the context of eradicating malaria. His presentation was based on a scientific briefing that was used in a preliminary foresight analysis project on gene drive and malaria. This project aimed to map the potential societal impact of gene-drive technology and exposed the need for a general risk assessment framework for biotechnological applications. Jens Steerteghem explained how the number of female mosquitos would be suppressed if the gene-drive method were applied: by introducing in males a gene on the Y chromosome that cuts their X chromosome, so that they only pass Y chromosomes to their offspring. This offspring are consequently exclusively male, and additionally carry the new gene on their Y chromosome.
Delphine Thizy, Stakeholder Engagement Manager with the non-profit research organisation Target Malaria delivered the second presentation. This organisation is developing the gene-drive technology method to reduce malaria. Delphine Thizy described the current state of the research at her organisation, commenting that only in September 2018, their team published a paper on a successful eradication experiment on a mosquito population in a containment cage. She also addressed some of the misconceptions and concerns she hears when explaining Target Malaria’s plans. These worries are expressed both by citizens in Western countries but also, and more importantly, from stakeholders in countries in sub-Saharan Africa that suffer from malaria. People question, for example, if the targeted mosquito species are crucial pollinators, or if the reduction of mosquitos would disturb food chains. For both cases, she indicated that there is no need to worry: the targeted mosquitoes are not known to be pollinators and just three mosquito species would be targeted out of 830 species in Africa alone.
NanoApps Medical, Inc. Aims To Develop Nanobiosensor for Malaria, Ebola, and Zika
News This Week
Particles that are mere nanometers in size are at the forefront of scientific research today. They come in many different shapes: rods, spheres, cubes, vesicles, S-shaped worms and even donut-like rings. What makes them [...]
Controlling the interactions between light and matter has been a long-standing ambition for scientists seeking to develop and advance numerous technologies that are fundamental to society. With the boom of nanotechnology in recent years, [...]
In her inaugural podcast, Jamilee interviews Frank Boehm of NanoApps Medical Inc and NanoApps Athletics Inc. From Jamilee's podcast: Welcome to the first episode of "In a Click". On todays show I chat with [...]
Frank Boehm (NanoApps Medical Inc. founder) and Amanda Scott (NA CEO) join NanoApps Athletics Inc. NanoApps Athletics Inc proposes a unique synergistic biochemical/nanomedical strategy for the expedited repair and healing of Achilles tendon micro [...]
In a paper published in Nature's NPJ Quantum Information ("Multiphoton quantum-state engineering using conditional measurements"), Omar Magaña-Loaiza, assistant professor in the Louisiana State University (LSU) Department of Physics & Astronomy, and his team of [...]
According to a report in the Financial Times, a team of researchers from Google led by John Martinis have demonstrated quantum supremacy for the first time. This is the point at which a quantum [...]
A new nanomaterial developed by scientists at the University of Bath could solve a conundrum faced by scientists probing some of the most promising types of future pharmaceuticals (Nanoscale Horizons, "Measuring optical [...]
Researchers at the Nanoscience Center and Faculty of Information Technology in the University of Jyväskylä, Finland, have achieved a significant step forward in predicting atomic structures of hybrid nanoparticles. A research article published in [...]
Nanomedical Device and Systems Design: Challenges, Possibilities, Visions now available to rent on Kindle
To accommodate students who wish to read the book at an affordable cost, Nanomedical Device and Systems Design: Challenges, Possibilities, Visions by Frank Boehm (CEO NanoApps Medical Inc.) is available to rent on Kindle. This book benefits [...]
Tools that detect cancer in its early stages can increase patient survival and quality of life. However, cancer screening approaches often call for expensive equipment and trips to the clinic, which may not be [...]
The blood-brain barrier is a physiological boundary layer that works highly selectively and thus protects the brain: On the one hand, pathogens or toxins are effectively prevented from penetrating the brain, on the other [...]